Contact
searchSearch
HMP Global

News

Smiling woman touching neck
News
Anatomy-Driven Model Aims to Prevent GLP-1 RA–Associated Facial Aging
10/01/2026
Coleen Stern, MA
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an anatomy-driven framework for identifying patients at risk for rapid, region-specific facial volume loss and intervening before visible facial aging progresses.
Researchers propose an...
10/01/2026
The Dermatologist
dkin
News
Review Reframes Skin Barrier as an Integrated Defense System
09/30/2026
Coleen Stern, MA
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an interconnected physical, chemical, immune, and microbial defense system rather than a single structural layer.
The skin barrier functions as an...
09/30/2026
The Dermatologist
News
Poor Cardiovascular-Kidney-Metabolic Health Linked to Psoriasis Risk, Reduced Life Expectancy
09/03/2026
Jessica Garlewicz
Poor cardiovascular-kidney-metabolic health was associated with an increased risk of developing psoriasis.
Poor cardiovascular-kidney-metabolic health was associated with an increased risk of developing psoriasis.
Poor...
09/03/2026
The Dermatologist
News
Routine Latent TB Testing Not Required With IL-17, IL-23 Inhibitors, Experts Say
09/03/2026
Jessica Garlewicz
Testing for latent tuberculosis infection has been standard practice among patients with psoriasis treated with IL-17 or IL-23 inhibitors. However, the experts noted that evidence supporting routine testing in these patients is weak.
Testing for latent tuberculosis infection has been standard practice among patients with psoriasis treated with IL-17 or IL-23 inhibitors. However, the experts noted that evidence supporting routine testing in these patients is weak.
Testing for latent tuberculosis...
09/03/2026
The Dermatologist
News
Lipidomics May Help Identify Biomarkers of Psoriasis Activity and Treatment Response
09/03/2026
Jessica Garlewicz
The review focused on identifying and characterizing lipid profile alterations in psoriasis and evaluating pro-inflammatory lipids as potential biomarkers of disease activity and treatment response.
The review focused on identifying and characterizing lipid profile alterations in psoriasis and evaluating pro-inflammatory lipids as potential biomarkers of disease activity and treatment response.
The review focused on...
09/03/2026
The Dermatologist
News
Global Psoriasis Burden Nearly Doubled Over 3 Decades, Economic Costs Reach $149 Billion
09/03/2026
Jessica Garlewicz
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in psoriasis cases, effects on quality of life, and associated economic costs.
Investigators assessed trends in...
09/03/2026
The Dermatologist
News
IBS Associated With 35% Higher Long-Term Risk of Psoriasis
08/12/2026
Jessica Garlewicz
Patients with irritable bowel syndrome (IBS) had a 35% higher risk of developing psoriasis compared with those without IBS in a large prospective cohort study.
Patients with irritable bowel syndrome (IBS) had a 35% higher risk of developing psoriasis compared with those without IBS in a large prospective cohort study.
Patients with irritable bowel...
08/12/2026
The Dermatologist
News
Psoriasis Associated With Increased Risk of Acute Periapical Abscesses
08/12/2026
Jessica Garlewicz
Patients with psoriasis had a significantly higher prevalence of acute periapical abscesses, with the association persisting after adjustment for several medical, behavioral, and treatment-related factors.
Patients with psoriasis had a significantly higher prevalence of acute periapical abscesses, with the association persisting after adjustment for several medical, behavioral, and treatment-related factors.
Patients with psoriasis had a...
08/12/2026
The Dermatologist
News
Patients, Dermatology Providers Support Telemedicine for Stable Psoriasis, Atopic Dermatitis
08/12/2026
Jessica Garlewicz
Patients with stable psoriasis or atopic dermatitis receiving systemic treatment and dermatological care providers reported positive attitudes toward telemedicine.
Patients with stable psoriasis or atopic dermatitis receiving systemic treatment and dermatological care providers reported positive attitudes toward telemedicine.
Patients with stable psoriasis...
08/12/2026
The Dermatologist
News
Expert Consensus Addresses Malignancy Risk With Targeted Therapies for Psoriasis, Atopic Dermatitis
08/12/2026
Jessica Garlewicz
The growing use of biologic and oral targeted therapies has expanded treatment options for psoriasis and atopic dermatitis, including among patients with cancer-related risks.
The growing use of biologic and oral targeted therapies has expanded treatment options for psoriasis and atopic dermatitis, including among patients with cancer-related risks.
The growing use of biologic and...
08/12/2026
The Dermatologist

Popular Articles

Brain
Quiz
Barriers to Mental Health Support
10/10/2024
Riya Gandhi, MA
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to mental health support for patients with atopic dermatitis identified in the NEA survey?
What was the first barrier to...
10/10/2024
The Dermatologist
Derm Dx
What Is the Scaly Erythematous Plaque on the Left Upper Cheek?
10/07/2024
Aamir N. Hussain, MD, MAPP; Amor Khachemoune, MD, FAAD, FACMS; Tebyan Khalfalla, BS
A 96-year-old woman presented to the dermatology clinic with a scaly plaque on her left cheek that had been there for many years.
A 96-year-old woman presented to the dermatology clinic with a scaly plaque on her left cheek that had been there for many years.
A 96-year-old woman presented to...
10/07/2024
The Dermatologist
Cover Story
Dermatology Disruptors: Next-Generation Skin Microbiome Testing and Bacteriophage Therapy
10/07/2024
Seaver L. Soon, MD; Nathan Brown, PhD
This precision medicine approach to inflammatory skin disease prioritizes a view of the skin microbiome by utilizing bacteriophage therapy, the viruses that target and destroy specific strains of bacteria, based on individual patient skin...
This precision medicine approach to inflammatory skin disease prioritizes a view of the skin microbiome by utilizing bacteriophage therapy, the viruses that target and destroy specific strains of bacteria, based on individual patient skin...
This precision medicine approach...
10/07/2024
The Dermatologist
Atopic dermatitis
Quiz
Pediatric Atopic Dermatitis Management
11/11/2024
Riya Gandhi, MA
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies does Dr Lisa Swanson suggest for children who have difficulty adhering to topical treatment regimens?a) Antibioticsb) Injectable or oral medicationsc) UV light therapyd) Homeopathic remedies2. According to Dr...
1. What alternative therapies...
11/11/2024
The Dermatologist
Chief Medical Editor Message
The Microbiome
10/06/2024
Steven R. Feldman, MD, PhD
Dermatology and our patients have benefited greatly from scientific advances over the past decades.
Dermatology and our patients have benefited greatly from scientific advances over the past decades.
Dermatology and our patients...
10/06/2024
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use